SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-20-037983
Filing Date
2020-02-14
Accepted
2020-02-14 15:29:03
Documents
2
Group Members
BLACKSTONE CLARUS GP L.L.CBLACKSTONE CLARUS GP L.P.BLACKSTONE GROUP INC.BLACKSTONE GROUP MANAGEMENT L.L.C.BLACKSTONE HOLDINGS I/II GP L.L.C.CLARUS IV GP, L.P.CLARUS IV-A, L.P.CLARUS IV-B, L.P.CLARUS IV-C, L.P.CLARUS IV-D, L.P.STEPHEN A. SCHWARZMAN

Document Format Files

Seq Description Document Type Size
1 SC 13G d886336dsc13g.htm SC 13G 205230
2 EXHIBIT A d886336dex99a.htm EX-99.A 18221
  Complete submission text file 0001193125-20-037983.txt   225332
Mailing Address C/O THE BLACKSTONE GROUP 345 PARK AVENUE NEW YORK NY 10154
Business Address C/O THE BLACKSTONE GROUP 345 PARK AVENUE NEW YORK NY 10154 212-583-5000
Blackstone Holdings II L.P. (Filed by) CIK: 0001484870 (see all company filings)

IRS No.: 260288604
Type: SC 13G

Mailing Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355
Business Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Subject) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91201 | Film No.: 20618724
SIC: 2834 Pharmaceutical Preparations